AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2007
Dec 14, 2007
30826_dirs_2007-12-14_6ed6ebf4-54e0-457b-9ad5-b94e9de5d94e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2007-12-13
Reporting Person: RUSCHE JAMES R (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-12-13 | Common Stock | M | 30000 | $1.41 | Acquired | 115874 | Direct |
| 2007-12-13 | Common Stock | S | 900 | $6.17 | Disposed | 0 | Direct |
| 2007-12-13 | Common Stock | S | 2357 | $6.15 | Disposed | 0 | Direct |
| 2007-12-13 | Common Stock | S | 12443 | $6.14 | Disposed | 0 | Direct |
| 2007-12-13 | Common Stock | S | 2200 | $6.13 | Disposed | 0 | Direct |
| 2007-12-13 | Common Stock | S | 2100 | $6.12 | Disposed | 0 | Direct |
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23